WJA
AMGN icon

Willis Johnson & Associates’s Amgen AMGN Stock Holding History

Willis Johnson & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,012
Closed -$283K – 192
2025
Q2 		$283K Hold
1,012
– – 0.02% 136
2025
Q1 		$315K Buy
+1,012
New +$299K 0.02% 121
2023
Q1 		– Sell
-786
Closed -$206K – 119
2022
Q4 		$206K Buy
+786
New +$211K 0.03% 108

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Willis Johnson & Associates's AMGN Position: Q3 2025 in Review

Willis Johnson & Associates sold out of Amgen (AMGN) in Q3 2025, closing a stake of 1,012 shares — an estimated $283K sold.

Willis Johnson & Associates first reported a position in AMGN in Q4 2022 and held it in 3 quarters. The position peaked at $315K in Q1 2025. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Willis Johnson & Associates reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Willis Johnson & Associates sold 1,012 Amgen shares in Q3 2025, an estimated $283K.
  • Willis Johnson & Associates first reported a position in Amgen in Q4 2022 and held it in 3 quarters.
  • Willis Johnson & Associates's Amgen position peaked at $315K in Q1 2025.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Willis Johnson & Associates's 13F filing for Q3 2025, filed 6 Nov 2025.